CA2158482A1 - UCF1 Compounds, Derivatives Thereof and Processes for Their Preparation - Google Patents
UCF1 Compounds, Derivatives Thereof and Processes for Their PreparationInfo
- Publication number
- CA2158482A1 CA2158482A1 CA 2158482 CA2158482A CA2158482A1 CA 2158482 A1 CA2158482 A1 CA 2158482A1 CA 2158482 CA2158482 CA 2158482 CA 2158482 A CA2158482 A CA 2158482A CA 2158482 A1 CA2158482 A1 CA 2158482A1
- Authority
- CA
- Canada
- Prior art keywords
- compounds
- ucf1
- derivatives
- see
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Compounds UCF1 and derivatives thereof exhibit anti-bacterial and anti-tumour activities and may be used for the preparation of anti-bacterial and anti-tumour agents.
Compounds UCF1 may be produced by fermentation of a microorganism of the genus Streptomyces capable of producing compounds UCF1, preferably Streptomyces sp.
UOF1 (FERM BP-2844) and recovering the desired compounds from the cultured broth.
The compounds UCF1 have the formula (see fig. I) (I) [wherein R represents either (see fig. II) or (see fig. III) The compounds may be oxidised to obtain derivatives of formula (see fig. IV) which exhibit similar pharmacological activities.
Compounds UCF1 may be produced by fermentation of a microorganism of the genus Streptomyces capable of producing compounds UCF1, preferably Streptomyces sp.
UOF1 (FERM BP-2844) and recovering the desired compounds from the cultured broth.
The compounds UCF1 have the formula (see fig. I) (I) [wherein R represents either (see fig. II) or (see fig. III) The compounds may be oxidised to obtain derivatives of formula (see fig. IV) which exhibit similar pharmacological activities.
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2120640A JP2854671B2 (en) | 1990-05-10 | 1990-05-10 | New substance UCF1 |
JP120,640/90 | 1990-05-10 | ||
JP320,439/90 | 1990-11-22 | ||
JP32043990 | 1990-11-22 | ||
CA002041237A CA2041237C (en) | 1990-05-10 | 1991-04-25 | Ucf1 compounds derivatives thereof and processes for their preparation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002041237A Division CA2041237C (en) | 1990-05-10 | 1991-04-25 | Ucf1 compounds derivatives thereof and processes for their preparation |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2158482A1 true CA2158482A1 (en) | 1991-11-11 |
CA2158482C CA2158482C (en) | 1997-10-07 |
Family
ID=27168898
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002158482A Expired - Fee Related CA2158482C (en) | 1990-05-10 | 1991-04-25 | Ucf1 compounds, derivatives thereof and processes for their preparation |
Country Status (1)
Country | Link |
---|---|
CA (1) | CA2158482C (en) |
-
1991
- 1991-04-25 CA CA002158482A patent/CA2158482C/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
CA2158482C (en) | 1997-10-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2388050A1 (en) | Antibiotic caprazamycins and process for producing the same | |
AU584136B2 (en) | CL-1577D and 1577E antibiotic/antitumor compounds, their production and use | |
DE3378059D1 (en) | Antitumor antibiotics | |
AU589943B2 (en) | CL - 1577 - B4 compound, its procuction and use | |
EP0350623A3 (en) | Bu-3420t antitumor antibiotic | |
EP0161849A3 (en) | Cl-1724 antibiotic-antitumour compounds, pharmaceutical compositions comprising the compounds and a novel microorganism for producing the compounds | |
CA2041237A1 (en) | UCF1 Compounds Derivatives Thereof and Processes for Their Preparation | |
CA2158482A1 (en) | UCF1 Compounds, Derivatives Thereof and Processes for Their Preparation | |
CA2028465A1 (en) | Novel anthracycline glycoside derivatives and preparing method thereof | |
CA2107110A1 (en) | Novel Immunosuppressant Agent from Streptomyces Braegensis | |
EP0491956A4 (en) | Reveromycin a, production thereof, and antitumor drug and fungicide | |
ZA884653B (en) | Antitumor agent obtained by microbial stereoselective reduction of 4'-deoxy-4'-iododoxorubicin | |
GB8802229D0 (en) | Ws-9326 & its derivatives | |
ES8801703A1 (en) | Micromonospora microorganisms and macrolide antibiotic production therewith. | |
EP0139457A3 (en) | An antibiotic compound and its production | |
CA2017276A1 (en) | Carcinostatic or Antitumor Antibiotic, Conagenin, and Production and Uses Thereof | |
CA2132869A1 (en) | Novel Rapamycin Producer | |
CA2019463A1 (en) | Antibiotics plusbacin | |
PT78325A (en) | Process for preparing novel macrolides ptl-448 | |
CA2029616A1 (en) | Chemical compound exhibiting anti-bacterial and anti-tumour activity | |
EP0136923A3 (en) | 2-amino-1,9-dihydro-6h-purin-6-one-7-oxide, the pharmaceutically acceptable salts and a process for the production thereof | |
EP0330874A3 (en) | Antibacterial and antitumor agents LL-E33288 epsilon-I and LL-E33288-epsilonBr, with processes and intermediates for producing said agents | |
EP0596112A4 (en) | Novel macrolide compound and production thereof. | |
TH4689EX (en) | New antibiotic Muriidomycin A, B, C and D. Processes for preparation and therapeutic benefit. | |
JPS5783280A (en) | Bacteria producing novel antibiotic substance |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |